In October I saw the GP about frequent urination. He did a DRE and found a nodule. Blood & Urine tests were okay PSA 1.1 but he found a urine infection and prescribed Nitrofurantoin for a week. I saw the Consultant who did a DRE and took a swab. I had an MRI, Flow Rate test and throat and abdomen scans. I'm worried sick about this. Why would they want to scan the abdomen? Has anybody had a similar experience?
Edited by member 11 Jan 2022 at 12:20 | Reason: Not specified
Hi Sam,
It took me around a week or so far blood to clear up, a few weeks for others on this site so it varies with the individual.
Good luck.
Kev.
Best wishes,
Chris
Hi Sam,No reason to be embarrassed.As for PSA testing, simply ask your GP for a PSA test, perhaps every year. The rate of change of PSA is actually a much more useful indicator than having one value.
No need to be embarrassed, it's the best result anyone could wish for, and one I would have taken all day long.
Best wishes.
Great result. I'm pleased with the BBC article raising awareness. Screening is an emotive issue, I'm sure we all agree that more accurate testing is welcome. The more members of the house of lords who are aware of this the better.
Dave
This was not my experience: I shot ketchup for several weeks after a 27-needle template. Totally normal: ketchup v brown sauce no cause for panic. Biopsy is non-trivial (and must spread cells: with hindsight I would have removed them from my "journey" and relied on MRIs.)
There is absolutely no evidence of TRUS biopsy spreading cancer cells (needle tracking). There are a small number of cases in the USA of alleged needle tracking as a result of template biopsy but these are uncorroborated and the US is rather more litigious than the UK so the claims may be financially motivated.
You cannot get a prostate cancer diagnosis without a biopsy except in extreme circumstances - where the man has such extensive bone mets that a biopsy is an unnecessary risk. MRIs alone can be wrong.
Yes: that’s why I say with hindsight. It’s not so much tracking as CTCs: the track environment is not one PCa favours. I remember a paper which correlated metastasis to CTCs. It observed a spike following biopsy but the risk of mets correlated to background levels of CTC. I’ll try and dig it out: Korea I think. Trouble is there are no controls, as you say.
Click through to become a member and gain access to support, information and real time replies.